Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001457612-22-000018)

Filing Details

Accession Number:: 0001457612-22-000018
Form Type:: 5
Zero Holdings:: No
Publication Time:: 2022-03-16 17:29:45
Reporting Period:: 2021-12-31

Accepted Time:: 2022-03-16 17:29:45
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1457612	Genocea Biosciences Inc.	GNCA	()	5

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1338185	Andrew Thomas Davis	C/O Genocea Biosciences, Inc. 100 Acorn Park Drive, 5Th Floor Cambridge MA 02140	Chief Medical Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Disposition	2021-04-02	948	$2.71	49,224	No	4	S	Direct
Common Stock	Disposition	2021-06-01	524	$2.23	48,700	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Sale of shares by the Reporting Person to cover personal income tax withholding obligations in connection with the vesting and settlement of restricted stock units. Sell-to-cover is required by the Issuer, and this sale does not represent a discretionary transaction by the Reporting Person.